Olmesartan-associated Gastritis Observed Over Time

A 61-year-old woman who had been taking olmesartan for 7 years complained of epigastric pain, diarrhea, loss of appetite, and weight loss. Esophagogastroduodenoscopy revealed roughened mucosa and erosions in the stomach and duodenum. An endoscopic biopsy failed to identify the cause of the mucosal disorder. Small-bowel capsule endoscopy revealed villous atrophy in the small bowel, which led to suspicion of olmesartan-associated sprue-like enteropathy and gastritis. After the discontinuation of olmesartan, the symptoms and gastric mucosal findings improved. A final diagnosis of olmesartan-associated gastritis was confirmed. Olmesartan-associated gastritis should be considered in patients taking olmesartan for upper gastrointestinal symptoms.

Authors

Institutions

Publication Details

Journal
Internal Medicine
Published
2024-11-27
DOI
https://doi.org/10.2169/internalmedicine.4551-24
Citations
3
Primary Topic
Helicobacter pylori-related gastroenterology studies
Type
article
Field-Weighted Citation Impact
1.72
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Olmesartan-associated Gastritis Observed Over Time

Chise Ueda, Satoshi Urakami, Madoka Takao, Yoshinori Morita et al.
3 citations
Internal Medicine
Helicobacter pylori-related gastroenterology studies
1.72
article

Olmesartan-associated Gastritis Observed Over Time

Chise Ueda, Satoshi Urakami, Madoka Takao, Yoshinori Morita, Tetsuya Yoshizaki, Takashi Toyonaga, Eri Nishikawa, Hirofumi Abe, Hitomi Hori, Hiroshi Tanabe, Yuzo Kodama, Ryosuke Ishida, Shinya Hoki, M. Fujisawa, Risa Ashizaki
article en
3 citations

Abstract

A 61-year-old woman who had been taking olmesartan for 7 years complained of epigastric pain, diarrhea, loss of appetite, and weight loss. Esophagogastroduodenoscopy revealed roughened mucosa and erosions in the stomach and duodenum. An endoscopic biopsy failed to identify the cause of the mucosal disorder. Small-bowel capsule endoscopy revealed villous atrophy in the small bowel, which led to suspicion of olmesartan-associated sprue-like enteropathy and gastritis. After the discontinuation of olmesartan, the symptoms and gastric mucosal findings improved. A final diagnosis of olmesartan-associated gastritis was confirmed. Olmesartan-associated gastritis should be considered in patients taking olmesartan for upper gastrointestinal symptoms.

Internal MedicineVol. 64(12)
Kobe University (JP)
Zero hunger
Openalex Percentile: Top 14%
Helicobacter pylori-related gastroenterology studies
1.72
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.